New Delhi metallo-β-lactamase-1: structure, inhibitors and detection of producers

Papers of special note have been highlighted as: •• of considerable interest

References

• 1 Morrill HJ, Pogue JM, Kaye KS, LaPlante KL. Treatment options for carbapenem-resistant Enterobacteriaceae infections. Open Forum Infect. Dis. 2, ofv050 (2015).
  MedlineGoogle Scholar
• 2 WHO. Antimicrobial resistance: global report on surveillance 2014. World Health Organisation, Geneva, Switzerland. www.who.int/drugresistance/documents/surveillancereport/en/.
  Google Scholar
• 3 Bush K, Fisher JF. Epidemiological expansion, structural studies, and clinical challenges of new beta-lactamases from Gram-negative bacteria. Ann. Rev. Microbiol. 65, 455–478 (2011).
  Medline CASGoogle Scholar
• 4 Yong D, Toleman MA, Giske CG et al. Characterization of a new metallo-β-lactamase gene, bla_NDM-1, and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India. Antimicrob. Agents Chemother. 53, 5046–5054 (2009). •• The first report of the blaNDM-1 gene and its characterization.
  Medline CASGoogle Scholar
• 5 Singh A. Science, names giving and names calling: change NDM-1 to PCM. Mens Sana Monogr. 9, 294–319 (2011).
  MedlineGoogle Scholar
• 6 Pollini S, Maradei S, Pecile P et al. FIM-1, a new acquired metallo-β-lactamase from a Pseudomonas aeruginosa clinical isolate from Italy. Antimicrob. Agents Chemother. 57, 410–416 (2013).
  Medline CASGoogle Scholar
• 7 Marrs ECL, Day KM, Perry JD. In vitro activity of mecillinam against Enterobacteriaceae with NDM-1 carbapenemase. J. Antimicrob. Chemother. 69, 2873–2875 (2014).
  Medline CASGoogle Scholar
• 8 Castanheira M, Deshpande LM, Mathai D, Bell JM, Jones RN, Mendes RE. Early dissemination of NDM-1- and OXA-181-producing Enterobacteriaceae in Indian hospitals: report from the SENTRY Antimicrobial Surveillance Program, 2006–2007. Antimicrob. Agents Chemother. 55, 1274–1278 (2011).
  Medline CASGoogle Scholar
• 9 Wailan AM, Paterson DL, Caffery M, Sowden D, Sidjabat HE. Draft genome sequence of NDM-5-producing Escherichia coli sequence type 648 and genetic context of bla_NDM-5 in Australia. Genome Announc. 3, e00194–15 (2015).
  MedlineGoogle Scholar
• 10 Nordmann P, Poirel L, Walsh TR, Livermore DM. The emerging NDM carbapenemases. Trends Microbiol. 19, 588–595 (2011).
  Medline CASGoogle Scholar
• 11 Rogers BA, Sidjabat HE, Silvey A et al. Treatment options for New Delhi metallo-beta-lactamase-harboring Enterobacteriaceae. Microb. Drug Res. 19, 100–103 (2013).
  Medline CASGoogle Scholar
• 12 Kumarasamy KK, Irfan S, Krishnan P et al. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect. Dis. 10, 597–602 (2010).
  Medline CASGoogle Scholar
• 13 Li J, Nation RL, Turnidge JD et al. Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections. Lancet Infect. Dis. 6, 589–601 (2006).
  Medline CASGoogle Scholar
• 14 Livermore DM, Warner M, Mushtaq S, Doumith M, Zhang J, Woodford N. What remains against carbapenem-resistant Enterobacteriaceae? Evaluation of chloramphenicol, ciprofloxacin, colistin, fosfomycin, minocycline, nitrofurantoin, temocillin and tigecycline. Int. J. Antimicrob. Agents 37, 415–419 (2011). •• The activity of a range of antibacterial agents was evaluated against 81 carbapenem-resistant Enterobacteriaceae isolates from the UK.
  Medline CASGoogle Scholar
• 15 Bercot B, Poirel L, Dortet L, Nordmann P. In vitro evaluation of antibiotic synergy for NDM-1-producing Enterobacteriaceae. J. Antimicrob. Chemother. 66, 2295–2297 (2011).
  Medline CASGoogle Scholar
• 16 Berrazeg M, Diene S, Medjahed L et al. New Delhi Metallo-beta-lactamase around the world: an eReview using Google Maps. Euro Surveill. 19, 20809 (2014).
  MedlineGoogle Scholar
• 17 Livermore DM, Walsh TR, Toleman M, Woodford N. Balkan NDM-1: escape or transplant? Lancet Infect. Dis. 11, 164 (2011).
  MedlineGoogle Scholar
• 18 Voulgari E, Gartzonika C, Vrioni G et al. The Balkan region: NDM-1-producing Klebsiella pneumoniae ST11 clonal strain causing outbreaks in Greece. J. Antimicrob. Chemother. 69, 2091–2097 (2014).
  Medline CASGoogle Scholar
• 19 Dortet L, Nordmann P, Poirel L. Association of the Emerging Carbapenemase NDM-1 with a bleomycin resistance protein in Enterobacteriaceae and Acinetobacter baumannii. Antimicrob. Agents Chemother. 56, 1693–1697 (2012).
  Medline CASGoogle Scholar
• 20 Day KM, Ali S, Mirza IA et al. Prevalence and molecular characterization of Enterobacteriaceae producing NDM-1 carbapenemase at a military hospital in Pakistan and evaluation of two chromogenic media. Diagnostic Microbiol. Infect. Dis. 75, 187–191 (2013).
  Medline CASGoogle Scholar
• 21 Bushnell G, Mitrani-Gold F, Mundy LM. Emergence of New Delhi metallo-beta-lactamase type 1-producing enterobacteriaceae and non-enterobacteriaceae: global case detection and bacterial surveillance. Int. J. Infect. Dis. 17, e325–e333 (2013).
  Medline CASGoogle Scholar
• 22 Poirel L, Hervé V, Hombrouck-Alet C, Nordmann P. Long-term carriage of NDM-1-producing Escherichia coli. J. Antimicrob. Chemother. 66, 2185–2186 (2011).
  Medline CASGoogle Scholar
• 23 Denis C, Poirel L, Carricajo A et al. Nosocomial transmission of NDM-1-producing Escherichia coli within a non-endemic area in France. Clin. Microbiol. Infect. 18, E128–E130 (2012).
  Medline CASGoogle Scholar
• 24 Johnson AP, Woodford N. Global spread of antibiotic resistance: the example of New Delhi metallo-β-lactamase (NDM)-mediated carbapenem resistance. J. Med. Microbiol. 62, 499–513 (2013).
  Medline CASGoogle Scholar
• 25 Walsh TR, Weeks J, Livermore DM, Toleman MA. Dissemination of NDM-1 positive bacteria in the New Delhi environment and its implications for human health: an environmental point prevalence study. Lancet Infect. Dis. 11, 355–362 (2011).
  MedlineGoogle Scholar
• 26 Bush K, Jacoby GA. Updated functional classification of beta-lactamases. Antimicrob. Agents Chemother. 54, 969–976 (2010).
  Medline CASGoogle Scholar
• 27 Garau G, García-Sáez I, Bebrone C et al. Update of the standard numbering scheme for class B β-lactamases. Antimicrob. Agents Chemother. 48, 2347–2349 (2004).
  Medline CASGoogle Scholar
• 28 Zhang H, Hao Q. Crystal structure of NDM-1 reveals a common β-lactam hydrolysis mechanism. FASEB J. 25, 2574–2582 (2011). •• The crystal structure of NDM-1 in complex with a hydrolyzed ampicillin at 1.3 Å resolution, and proposed hydrolysis mechanism.
  Medline CASGoogle Scholar
• 29 Green VL, Verma A, Owens RJ, Phillips SE, Carr SB. Structure of New Delhi metallo-beta-lactamase 1 (NDM-1). Acta Cryst. Section F Struct. Biol. Cryst. Commun. 67, 1160–1164 (2011).
  Medline CASGoogle Scholar
• 30 Liang ZJ, Li LC, Wang YY et al. Molecular Basis of NDM-1, a new antibiotic resistance determinant. PLoS ONE 6(8), (2011).
  Google Scholar
• 31 CLSI. Performance standards for antimicrobial susceptibility testing: twenty-fourth informational supplements. M100-S24. Clinical and Laboratory Standards Institute, Wayne, PA, USA. http://ncipd.org/control/images/NCIPD_docs/CLSI_M100-S24.pdf.
  Google Scholar
• 32 Hrabák J, ChudáČkova E, Papagiannitsis CC. Detection of carbapenemases in Enterobacteriaceae: a challenge for diagnostic microbiological laboratories. Clin. Microbiol. Infect. 20, 839–853 (2014). •• A comprehensive review of screening methods for suspected isolates leading to a proposed workflow for carbapenemase identification in diagnostic laboratories.
  Medline CASGoogle Scholar
• 33 Carvalhaes CG, Picão RC, Nicoletti AG, Xavier DE, Gales AC. Cloverleaf test (modified Hodge test) for detecting carbapenemase production in Klebsiella pneumoniae: be aware of false positive results. J. Antimicrob. Chemother. 65, 249–251 (2010).
  Medline CASGoogle Scholar
• 34 Perry JD, Naqvi SH, Mirza IA et al. Prevalence of faecal carriage of Enterobacteriaceae with NDM-1 carbapenemase at military hospitals in Pakistan, and evaluation of two chromogenic media. J. Antimicrob. Chemother. 66, 2288–2294 (2011).
  Medline CASGoogle Scholar
• 35 Girlich D, Poirel L, Nordmann P. Value of the modified Hodge Test for detection of emerging carbapenemases in Enterobacteriaceae. J. Clin. Microbiol. 50, 477–479 (2012).
  Medline CASGoogle Scholar
• 36 Lee K, Lim YS, Yong D, Yum JH, Chong Y. Evaluation of the Hodge test and the imipenem-EDTA double-disk synergy test for differentiating metallo-beta-lactamase-producing isolates of Pseudomonas spp. and Acinetobacter spp. J. Clin. Microbiol. 41, 4623–4629 (2003).
  Medline CASGoogle Scholar
• 37 Bartolini A, Frasson I, Cavallaro A, Richter SN, Palu G. Comparison of phenotypic methods for the detection of carbapenem non-susceptible Enterobacteriaceae. Gut Pathog. 6(13), doi: 10.1186/1757-4749-6-13 (2014).
  MedlineGoogle Scholar
• 38 HPA. UK Standards for microbiology investigations: laboratory detection and reporting of bacteria with carbapenem-hydrolysing β-lactamases (carbapenemases) (1.1) (2014). www.gov.uk/government/uploads/system/uploads/attachment_data/file/344071/P_8i1.1.pdf.
  Google Scholar
• 39 Bora A, Ahmed G. Detection of NDM-1 in clinical isolates of Klebsiella pneumoniae from northeast India. J. Clin. Diagn. Res. 6, 794–800 (2012).
  CASGoogle Scholar
• 40 Nordmann P, Poirel L, Carrer A, Toleman MA, Walsh TR. How to detect NDM-1 producers. J. Clin. Microbiol. 49, 718–721 (2011).
  MedlineGoogle Scholar
• 41 Dortet L, Poirel L, Nordmann P. Rapid detection of carbapenemase-producing Pseudomonas spp. J. Clin. Microbiol. 50, 3773–3776 (2012).
  Medline CASGoogle Scholar
• 42 Tijet N, Boyd D, Patel SN, Mulvey MR, Melano RG. Evaluation of the Carba NP test for rapid detection of carbapenemase-producing Enterobacteriaceae and Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 57, 4578–4580 (2013).
  Medline CASGoogle Scholar
• 43 Xu D, Zhang Y. Generating triangulated macromolecular surfaces by Euclidean distance transform. PLoS ONE 4, e8140 (2009).
  MedlineGoogle Scholar
• 44 Moreland JL, Gramada A, Buzko OV, Zhang Q, Bourne PE. The Molecular Biology Toolkit (MBT): a modular platform for developing molecular visualization applications. BMC Bioinform. 6, 1–7 (2005).
  MedlineGoogle Scholar
• 45 Kim Y, Cunningham MA, Mire J, Tesar C, Sacchettini J, Joachimiak A. NDM-1, the ultimate promiscuous enzyme: substrate recognition and catalytic mechanism. FASEB J. 27, 1917–1927 (2013). •• Results of experimental and theoretical studies examining the substrate, metal binding and catalytic mechanism of the enzyme.
  Medline CASGoogle Scholar
• 46 Cuzon G, Naas T, Bogaerts P, Glupczynski Y, Nordmann P. Evaluation of a DNA microarray for the rapid detection of extended-spectrum β-lactamases (TEM, SHV and CTX-M), plasmid-mediated cephalosporinases (CMY-2-like, DHA, FOX, ACC-1, ACT/MIR and CMY-1-like/MOX) and carbapenemases (KPC, OXA-48, VIM, IMP and NDM). J. Antimicrob. Chemother. 67, 1865–1869 (2012).
  Medline CASGoogle Scholar
• 47 Vasoo S, Cunningham SA, Kohner PC et al. Rapid and direct real-time detection of bla_KPC and bla_NDM from surveillance samples. J. Clin. Microbiol. 51, 3609–3615 (2013).
  Medline CASGoogle Scholar
• 48 Huang L, Hu X, Zhou M et al. Rapid detection of New Delhi metallo-beta-lactamase gene and variants coding for carbapenemases with different activities by use of a PCR-based in vitro protein expression method. J. Clin. Microbiol. 52, 1947–1953 (2014).
  Medline CASGoogle Scholar
• 49 Kempf M, Bakour S, Flaudrops C et al. Rapid detection of carbapenem resistance in Acinetobacter baumannii using matrix-assisted laser desorption ionization-time of flight mass spectrometry. PLoS ONE 7, e0031676 (2012).
  Google Scholar
• 50 Hrabak J, Chudackova E, Walkova R. Matrix-assisted laser desorption ionization-time of flight (MALDI-TOF) mass spectrometry for detection of antibiotic resistance mechanisms: from research to routine diagnosis. Clin. Microbiol. Rev. 26, 103–114 (2013).
  Medline CASGoogle Scholar
• 51 Johansson Å, Ekelöf J, Giske CG, Sundqvist M. The detection and verification of carbapenemases using ertapenem and matrix assisted laser desorption ionization-time of flight. BMC Microbiol. 14, 1–8 (2014).
  Google Scholar
• 52 Hrabák J, Studentová V, Walková R et al. Detection of NDM-1, VIM-1, KPC, OXA-48, and OXA-162 carbapenemases by matrix-assisted laser desorption ionization-time of flight mass spectrometry. J. Clin. Microbiol. 50, 4441–2443 (2012).
  Google Scholar
• 53 Bernabeu S, Poirel L, Nordmann P. Spectrophotometry-based detection of carbapenemase producers among Enterobacteriaceae. Diagn. Microbiol. Infect. Dis. 741, 88–90 (2012).
  Google Scholar
• 54 Godtfredsen WO. An introduction to mecillinam. J. Antimicrob. Chemother. 3(Suppl. B), 1–4 (1977).
  MedlineGoogle Scholar
• 55 Buynak JD. beta-lactamase inhibitors: a review of the patent literature (2010–2013). Exp. Opin. Therap. Pat. 23, 1469–1481 (2013).
  Medline CASGoogle Scholar
• 56 King D, Strynadka N. Crystal structure of New Delhi metallo-β-lactamase reveals molecular basis for antibiotic resistance. Protein Sci. 20, 1484–1491 (2011). •• Crystal structure of apo-NDM-1 2.1 Å suggesting a molecular basis for broad-spectrum antibiotic resistance.
  Medline CASGoogle Scholar
• 57 Guo Y, Wang J, Niu G et al. A structural view of the antibiotic degradation enzyme NDM-1 from a superbug. Protein Cell 2, 384–394 (2011).
  Medline CASGoogle Scholar
• 58 RSCB. www.rcsb.org.
  Google Scholar
• 59 Thomas PW, Zheng M, Wu S et al. Characterization of purified New Delhi metallo-beta-lactamase-1. Biochemistry 50, 10102–10113 (2011).
  Medline CASGoogle Scholar
• 60 Yang H, Aitha M, Hetrick AM, Richmond TK, Tierney DL, Crowder MW. Mechanistic and spectroscopic studies of metallo-β-lactamase NDM-1. Biochemistry 51, 3839–3847 (2012).
  Medline CASGoogle Scholar
• 61 NCBI. Beta-Lactamase Data Resources. http://www.ncbi.nlm.nih.gov/pathogens/beta-lactamase-data-resources/.
  Google Scholar
• 62 Kaase M, Nordmann P, Wichelhaus TA, Gatermann SG, Bonnin RA, Poirel L. NDM-2 carbapenemase in Acinetobacter baumannii from Egypt. J. Antimicrob. Chemother. 66, 1260–1262 (2011).
  Medline CASGoogle Scholar
• 63 Zou D, Huang Y, Zhao X et al. A novel New Delhi metallo-beta-lactamase variant, NDM-14, isolated in a Chinese hospital possesses increased enzymatic activity against carbapenems. Antimicrob. Agents Chemother. 59, 2450–2453 (2015).
  Medline CASGoogle Scholar
• 64 Nordmann P, Boulanger AE, Poirel L. NDM-4 metallo-β-lactamase with increased carbapenemase activity from Escherichia coli. Antimicrob. Agents Chemother. 56, 2184–2186 (2012).
  Medline CASGoogle Scholar
• 65 Gottig S, Hamprecht AG, Christ S, Kempf VAJ, Wichelhaus TA. Detection of NDM-7 in Germany, a new variant of the New Delhi metallo-beta-lactamase with increased carbapenemase activity. J. Antimicrob. Chemother. 68, 1737–1740 (2013).
  MedlineGoogle Scholar
• 66 King DT, Worrall LJ, Gruninger R, Strynadka NC. New Delhi metallo-beta-lactamase: structural insights into beta-lactam recognition and inhibition. J. Am. Chem. Soc. 134, 11362–11365 (2012). •• Crystal structure of NDM-1 bound to competitive inhibitor L-captopril, suggesting important features for the design of inhibitors of NDM-1.
  Medline CASGoogle Scholar
• 67 Wang Z, Fast W, Valentine AM, Benkovic SJ. Metallo-beta-lactamase: structure and mechanism. Curr. Opin. Chem. Biol. 3, 614–622 (1999).
  Medline CASGoogle Scholar
• 68 Chiou J, Leung TY-C, Chen S. Molecular mechanisms of substrate recognition and specificity of New Delhi metallo-β-lactamase. Antimicrob. Agents Chemother. 58, 5372–5378 (2014). •• Examines substrate recognition and selectivity with important conclusions for inhibitor design.
  MedlineGoogle Scholar
• 69 Zhu KK, Lu JY, Ye F et al. Structure-based computational study of the hydrolysis of New Delhi metallo-beta-lactamase-1. Biochem. Biophys. Res. Commun. 431, 2–7 (2013).
  Medline CASGoogle Scholar
• 70 Zheng M, Xu DG. New Delhi Metallo-beta-lactamase I: substrate binding and catalytic mechanism. J. Phys. Chem. B 117, 11596–11607 (2013).
  Medline CASGoogle Scholar
• 71 Livermore DM, Mushtaq S, Morinaka A, Ida T, Maebashi K, Hope R. Activity of carbapenems with ME1071 (disodium 2,3-diethylmaleate) against Enterobacteriaceae and Acinetobacter spp. with carbapenemases, including NDM enzymes. J. Antimicrob. Chemother. 68, 153–158 (2013).
  Medline CASGoogle Scholar
• 72 Lienard BM, Garau G, Horsfall L et al. Structural basis for the broad-spectrum inhibition of metallo-beta-lactamases by thiols. Org. Biomol. Chem. 6, 2282–2294 (2008).
  Medline CASGoogle Scholar
• 73 Bebrone C. Metallo-beta-lactamases (classification, activity, genetic organization, structure, zinc coordination) and their superfamily. Biochem. Pharmacol. 74, 1686–1701 (2007).
  Medline CASGoogle Scholar
• 74 Li N, Xu Y, Xia Q et al. Simplified captopril analogues as NDM-1 inhibitors. Bioorg. Med. Chem. Lett. 24, 386–389 (2014).
  Medline CASGoogle Scholar
• 75 Ehlers MR, Riordan JF. Angiotensin-converting enzyme: zinc- and inhibitor-binding stoichiometries of the somatic and testis isozymes. Biochemistry 30, 7118–7126 (1991).
  Medline CASGoogle Scholar
• 76 Jacobsen JA, Major Jourden JL, Miller MT, Cohen SM. To bind zinc or not to bind zinc: an examination of innovative approaches to improved metalloproteinase inhibition. Biochim. Biophys. Acta 1803, 72–94 (2010).
  Medline CASGoogle Scholar
• 77 Klingler F-M, Wichelhaus TA, Frank D et al. Approved drugs containing thiols as inhibitors of metallo-beta-lactamases: strategy to combat multidrug-resistant bacteria. J. Med. Chem. 58, 3626–3630 (2015).
  Medline CASGoogle Scholar
• 78 Shen B, Yu Y, Chen H et al. Inhibitor discovery of full-length New Delhi metallo-beta-lactamase-1 (NDM-1). PLoS ONE 8, e62955 (2013).
  Medline CASGoogle Scholar
• 79 Zhang YL, Yang KW, Zhou YJ, LaCuran AE, Oelschlaeger P, Crowder MW. Diaryl-substituted azolylthioacetamides: inhibitor discovery of New Delhi metallo-beta-lactamase-1 (NDM-1). ChemMedChem 9, 2445–2448 (2014).
  Medline CASGoogle Scholar
• 80 Liu X-L, Shi Y, Kang JS, Oelschlaeger P, Yang K-W. Amino acid thioester derivatives: a highly promising scaffold for the development of metallo-beta-lactamase L1 inhibitors. ACS Med. Chem. Lett. 6, 660–664 (2015).
  Medline CASGoogle Scholar
• 81 Ma J, McLeod S, MacCormack K et al. Real-time monitoring of New Delhi metallo-beta-lactamase activity in living bacterial cells by H-1 NMR spectroscopy. Angew. Chem. Int. Ed. Engl. 53, 2130–2133 (2014).
  Medline CASGoogle Scholar
• 82 Ma J, Cao Q, McLeod SM et al. Target-based whole-cell screening by H-1 NMR spectroscopy. Angew. Chem. Int. Ed. Engl. 54, 4764–4767 (2015).
  Medline CASGoogle Scholar
• 83 Chen X, Li LX, Chen S et al. Identification of inhibitors of the antibiotic-resistance target New Delhi metallo-beta-lactamase 1 by both nanoelectrospray ionization mass spectrometry and ultrafiltration liquid chromatography/mass spectrometry approaches. Anal. Chem. 85, 7957–7965 (2013).
  Medline CASGoogle Scholar
• 84 Wang X, Lu M, Shi Y, Ou Y, Cheng X. Discovery of novel New Delhi metallo-beta-lactamases-1 inhibitors by multistep virtual screening. PLoS ONE 10, e0118290 (2015).
  MedlineGoogle Scholar
• 85 Li T, Wang Q, Chen F et al. Biochemical characteristics of New Delhi metallo-β-lactamase-1 show unexpected difference to other MBLs. PLoS ONE 8, e61914 (2013).
  Medline CASGoogle Scholar
• 86 Drawz SM, Papp-Wallace KM, Bonomo RA. New beta-lactamase inhibitors: a therapeutic renaissance in an MDR world. Antimicrob. Agents Chemother. 58, 1835–1846 (2014).
  MedlineGoogle Scholar
• 87 Yoshizumi A, Ishii Y, Livermore DM et al. Efficacies of calcium-EDTA in combination with imipenem in a murine model of sepsis caused by Escherichia coli with NDM-1 beta-lactamase. J. Infect. Chemother. 19, 992–995 (2013).
  Medline CASGoogle Scholar
• 88 Somboro AM, Tiwari D, Bester LA et al. NOTA: a potent metallo-beta-lactamase inhibitor. J. Antimicrob. Chemother. 70, 1594–1596 (2015).
  MedlineGoogle Scholar
• 89 Livermore DM, Mushtaq S, Morinaka A, Ida T, Maebashi K, Hope R. Activity of carbapenems with ME1071 (disodium 2,3-diethylmaleate) against Enterobacteriaceae and Acinetobacter spp. with carbapenemases, including NDM enzymes. J. Antimicrob. Chemother. 68, 153–158 (2013).
  Medline CASGoogle Scholar
• 90 King AM, Reid-Yu SA, Wang W et al. Aspergillomarasmine A overcomes metallo-beta-lactamase antibiotic resistance. Nature 510, 503–506 (2014).
  Medline CASGoogle Scholar
• 91 von Nussbaum F, Schiffer G. Aspergillomarasmine A, an inhibitor of bacterial metallo-beta-lactamases conferring bla(NDM) and bla(VIM) resistance. Angew. Chem. Int. Ed. Engl. 53, 11696–11698 (2014).
  Medline CASGoogle Scholar
• 92 Mikami Y, Suzuki T. Novel microbial inhibitors of angiotensin-converting enzyme, Aspergillomarasmines A and B. Agric. Biol. Chem. 47, 2693–2695 (1983).
  CASGoogle Scholar
• 93 Arai K, Ashikawa N, Nakakita Y, Matsuura A, Ashizawa N, Munekata M. Aspergillomarasmine A and B, potent microbial inhibitors of endothelin-converting enzyme. Biosci. Biotech. Biochem. 57, 1944–1945 (1993).
  CASGoogle Scholar
• 94 Matsuura A, Okumura H, Asakura R et al. Pharmacological profiles of aspergillomarasmines as endothelin converting enzyme inhibitors. Jpn J. Pharmacol. 63, 187–193 (1993).
  Medline CASGoogle Scholar
• 95 Rydzik AM, Brem J, van Berkel SS et al. Monitoring Conformational Changes in the NDM-1 metallo-beta-lactamase by ¹⁹F NMR Spectroscopy. Angew. Chem. Int. Ed. Engl. 53, 3129–3133 (2014).
  Medline CASGoogle Scholar
• 96 Klingler FM, Moser D, Buttner D et al. Probing metallo-beta-lactamases with molecular fragments identified by consensus docking. Bioorg. Med. Chem. Lett. 25, 5243–5246 (2015).
  Medline CASGoogle Scholar
• 97 Gan M, Liu Y, Bai Y et al. Polyketides with New Delhi metallo-beta-lactamase 1 inhibitory activity from Penicillium sp. J. Nat. Prod. 76, 1535–1540 (2013).
  Medline CASGoogle Scholar
• 98 Thomas PW, Spicer T, Cammarata M, Brodbelt JS, Hodder P, Fast W. An altered zinc-binding site confers resistance to a covalent inactivator of New Delhi metallo-beta-lactamase-1 (NDM-1) discovered by high-throughput screening. Bioorg. Med. Chem. 21, 3138–3146 (2013).
  Medline CASGoogle Scholar
• 99 Chiou JC, Wan SB, Chan KF et al. Ebselen as a potent covalent inhibitor of New Delhi metallo-beta-lactamase (NDM-1). Chem. Commun. 51, 9543–9546 (2015).
  Medline CASGoogle Scholar
• 100 Thomas PW, Cammarata M, Brodbelt JS, Fast W. Covalent inhibition of New Delhi metallo-beta-lactamase-1 (NDM-1) by cefaclor. ChemBioChem 15, 2541–2548 (2014).
  Medline CASGoogle Scholar
• 101 Yang K-W, Feng L, Yang S-K et al. New beta-phospholactam as a carbapenem transition state analog: synthesis of a broad-spectrum inhibitor of metallo-beta-lactamases. Bioorg. Med. Chem. Lett. 23, 5855–5859 (2013).
  Medline CASGoogle Scholar
• 102 van Berkel SS, Brem J, Rydzik AM et al. Assay platform for clinically relevant metallo-beta-lactamases. J. Med. Chem. 56, 6945–6953 (2013).
  Medline CASGoogle Scholar
• 103 Worthington RJ, Bunders CA, Reed CS, Melander C. Small molecule suppression of carbapenem resistance in NDM-1 producing Klebsiella pneumoniae. ACS Med. Chem. Lett. 3, 357–361 (2012).
  Medline CASGoogle Scholar
• 104 Randhawa V, Jamwal R. Molecular modeling and virtual screening studies of NDM-1 beta lactamase for identification of a series of potent inhibitors. Int. Res. J. Biochem. Bioinform. 1, 95–102 (2011).
  Google Scholar
• 105 Oelschlaeger P, Ai N, Duprez KT, Welsh WJ, Toney JH. Evolving carbapenemases: can medicinal chemists advance one step ahead of the coming storm? J. Med. Chem. 53, 3013–3027 (2010).
  Medline CASGoogle Scholar
• 106 Repasky MP, Shelley M, Friesner RA. Flexible ligand docking with glide. Curr. Protoc. Bioinform. 8(Unit 8), 12 (2002).
  Google Scholar
• 107 Vaara M. Agents that increase the permeability of the outer membrane. Microbiol. Rev. 56, 395–411 (1992).
  Medline CASGoogle Scholar
• 108 Franz KJ. Clawing back: broadening the notion of metal chelators in medicine. Curr. Opin. Chem. Biol. 17, 143–149 (2013).
  Medline CASGoogle Scholar